193 related articles for article (PubMed ID: 27869573)
41. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
Ludwig A; Schulte A; Schnack C; Hundhausen C; Reiss K; Brodway N; Held-Feindt J; Mentlein R
J Neurochem; 2005 Jun; 93(5):1293-303. PubMed ID: 15934948
[TBL] [Abstract][Full Text] [Related]
42. Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis : studies in mice with K/BxN serum-induced arthritis.
Isozaki T; Arbab AS; Haas CS; Amin MA; Arendt MD; Koch AE; Ruth JH
Arthritis Rheum; 2013 Jul; 65(7):1736-46. PubMed ID: 23633118
[TBL] [Abstract][Full Text] [Related]
43. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
Deng L; Chen N; Li Y; Zheng H; Lei Q
Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
[TBL] [Abstract][Full Text] [Related]
44. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
[TBL] [Abstract][Full Text] [Related]
45. CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity.
Freeman CM; Curtis JL; Chensue SW
Am J Pathol; 2007 Sep; 171(3):767-76. PubMed ID: 17640964
[TBL] [Abstract][Full Text] [Related]
46. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
47. Annulus fibrosus cells express and utilize C-C chemokine receptor 5 (CCR5) for migration.
Liu W; Liu D; Zheng J; Shi P; Chou PH; Oh C; Chen D; An HS; Chee A
Spine J; 2017 May; 17(5):720-726. PubMed ID: 28108404
[TBL] [Abstract][Full Text] [Related]
48. "Inverse signaling" of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells.
Hattermann K; Bartsch K; Gebhardt HH; Mehdorn HM; Synowitz M; Schmitt AD; Mentlein R; Held-Feindt J
Cell Commun Signal; 2016 Oct; 14(1):26. PubMed ID: 27784296
[TBL] [Abstract][Full Text] [Related]
49. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
[TBL] [Abstract][Full Text] [Related]
50. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.
Gao Q; Zhao YJ; Wang XY; Qiu SJ; Shi YH; Sun J; Yi Y; Shi JY; Shi GM; Ding ZB; Xiao YS; Zhao ZH; Zhou J; He XH; Fan J
Cancer Res; 2012 Jul; 72(14):3546-56. PubMed ID: 22710437
[TBL] [Abstract][Full Text] [Related]
51. Increased expression of CXCL16, a bacterial scavenger receptor, in the colon of children with ulcerative colitis.
Kalliomäki M; Rajala S; Elamo H; Ashorn M; Ruuska T
J Crohns Colitis; 2014 Oct; 8(10):1222-6. PubMed ID: 24630488
[TBL] [Abstract][Full Text] [Related]
52. CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis.
Martini G; Cabrelle A; Calabrese F; Carraro S; Scquizzato E; Teramo A; Facco M; Zulian F; Agostini C
Clin Immunol; 2008 Nov; 129(2):268-76. PubMed ID: 18760678
[TBL] [Abstract][Full Text] [Related]
53. CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results.
Zivković M; Djurić T; Stojković L; Jovanović I; Končar I; Davidović L; Veljković N; Alavantić D; Stanković A
J Atheroscler Thromb; 2015; 22(1):10-20. PubMed ID: 25142184
[TBL] [Abstract][Full Text] [Related]
54. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance.
Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K
J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769
[TBL] [Abstract][Full Text] [Related]
55. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
Smith C; Halvorsen B; Otterdal K; Waehre T; Yndestad A; Fevang B; Sandberg WJ; Breland UM; Frøland SS; Oie E; Gullestad L; Damås JK; Aukrust P
Cardiovasc Res; 2008 Jul; 79(1):195-203. PubMed ID: 18339644
[TBL] [Abstract][Full Text] [Related]
56. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
[TBL] [Abstract][Full Text] [Related]
57. Production and expression of RANTES (CCL5) by human disc cells and modulation by IL-1-β and TNF-α in 3D culture.
Gruber HE; Hoelscher GL; Ingram JA; Bethea S; Norton HJ; Hanley EN
Exp Mol Pathol; 2014 Apr; 96(2):133-8. PubMed ID: 24468005
[TBL] [Abstract][Full Text] [Related]
58. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
[TBL] [Abstract][Full Text] [Related]
59. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
[TBL] [Abstract][Full Text] [Related]
60. Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDL.
Gursel M; Klinman DM; Gursel I
Mediators Inflamm; 2013; 2013():312590. PubMed ID: 24302814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
